Details for New Drug Application (NDA): 020929

✉ Email this page to a colleague

NDA 020929 describes PULMICORT RESPULES, which is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. Additional details are available on the PULMICORT RESPULES profile page.

The generic ingredient in PULMICORT RESPULES is budesonide. There are twenty-two drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the budesonide profile page.

Summary for 020929

Tradename:	PULMICORT RESPULES
Applicant:	Astrazeneca
Ingredient:	budesonide
Patents:	0

Pharmacology for NDA: 020929

Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for 020929

Anti-Inflammatory Agents
Bronchodilator Agents
Glucocorticoids

Suppliers and Packaging for NDA: 020929

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PULMICORT RESPULES	budesonide	SUSPENSION;INHALATION	020929	NDA	AstraZeneca Pharmaceuticals LP	0186-1988	0186-1988-04	6 POUCH in 1 CARTON (0186-1988-04) / 5 AMPULE in 1 POUCH / 2 mL in 1 AMPULE
PULMICORT RESPULES	budesonide	SUSPENSION;INHALATION	020929	NDA	AstraZeneca Pharmaceuticals LP	0186-1989	0186-1989-04	6 POUCH in 1 CARTON (0186-1989-04) / 5 AMPULE in 1 POUCH / 2 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SUSPENSION;INHALATION			Strength	0.25MG/2ML
Approval Date:	Aug 8, 2000	TE:	AN	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	SUSPENSION;INHALATION			Strength	0.5MG/2ML
Approval Date:	Aug 8, 2000	TE:	AN	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	SUSPENSION;INHALATION			Strength	1MG/2ML
Approval Date:	Aug 8, 2000	TE:	AN	RLD:	Yes

Expired US Patents for NDA 020929

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Astrazeneca	PULMICORT RESPULES	budesonide	SUSPENSION;INHALATION	020929-002	Aug 8, 2000	⤷ Get Started Free	⤷ Get Started Free
Astrazeneca	PULMICORT RESPULES	budesonide	SUSPENSION;INHALATION	020929-001	Aug 8, 2000	⤷ Get Started Free	⤷ Get Started Free
Astrazeneca	PULMICORT RESPULES	budesonide	SUSPENSION;INHALATION	020929-002	Aug 8, 2000	⤷ Get Started Free	⤷ Get Started Free
Astrazeneca	PULMICORT RESPULES	budesonide	SUSPENSION;INHALATION	020929-002	Aug 8, 2000	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.